A phase II trial of vinflunine as salvage chemotherapy in hormone refractory prostate cancer (HRPC).
Phase of Trial: Phase II
Latest Information Update: 11 Apr 2016
At a glance
- Drugs Vinflunine (Primary)
- Indications Prostate cancer
- Focus Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 27 Oct 2007 New trial record.